Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China · Delayed Price · Currency is CNY 22.07
-0.12 (-0.54%)
At close: Jun 11, 2026
SHA:603207 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 203.65 | 207.49 | 205.27 | 203.63 | 175.18 | 126.27 |
Depreciation & Amortization | 2.68 | 2.68 | 2.81 | 3.23 | 3.65 | 4.17 |
Other Amortization | 0.11 | 0.11 | 0.23 | 0.29 | 0.25 | 0.24 |
Loss (Gain) From Sale of Assets | -0.11 | -0.11 | - | - | -0 | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.27 | 0.06 |
Loss (Gain) From Sale of Investments | - | - | -0.02 | -2.25 | -2.96 | -2.83 |
Stock-Based Compensation | 2.91 | 2.91 | 0.79 | 1.99 | 4.08 | 43.78 |
Provision & Write-off of Bad Debts | 1.85 | 1.85 | 0.22 | 0.17 | 1.37 | -0.71 |
Other Operating Activities | -4.41 | -0.36 | 0.1 | 0.13 | 0.05 | 0.08 |
Change in Accounts Receivable | -48.72 | -48.72 | -6.76 | -4.39 | -33.68 | 12.74 |
Change in Inventory | -24.16 | -24.16 | 4.61 | 7.2 | -4.12 | -13.25 |
Change in Accounts Payable | 20.43 | 20.43 | 5.45 | -9.15 | -6.63 | 9.51 |
Operating Cash Flow | 152.91 | 160.8 | 212.21 | 200.26 | 137.2 | 179.51 |
Operating Cash Flow Growth | -27.18% | -24.23% | 5.97% | 45.96% | -23.57% | 1.37% |
Capital Expenditures | -82.29 | -54.24 | -83.94 | -80.15 | -61.59 | -12.48 |
Sale of Property, Plant & Equipment | 0.11 | 0.11 | - | - | - | 0.46 |
Investment in Securities | -9 | 356 | -450.1 | 107.27 | 54.02 | -97.57 |
Other Investing Activities | 5.43 | 4.14 | 3.09 | -0.72 | 0.9 | 5.19 |
Investing Cash Flow | -85.75 | 306.01 | -530.95 | 26.4 | -6.67 | -104.4 |
Short-Term Debt Issued | - | 1.12 | 1.65 | - | - | - |
Total Debt Issued | 0.61 | 1.12 | 1.65 | - | - | - |
Long-Term Debt Repaid | - | -0.4 | -0.23 | -0.45 | - | - |
Net Debt Issued (Repaid) | 0.21 | 0.72 | 1.43 | -0.45 | - | - |
Issuance of Common Stock | 3.32 | 8.38 | 472.36 | 1.98 | - | 3.4 |
Common Dividends Paid | -353.23 | -353.23 | - | - | -111.39 | -84.56 |
Other Financing Activities | 6.15 | -5.33 | -10.73 | -4.3 | -5.28 | -1.2 |
Financing Cash Flow | -343.55 | -349.47 | 463.06 | -2.78 | -116.67 | -82.36 |
Net Cash Flow | -276.39 | 117.34 | 144.31 | 223.87 | 13.85 | -7.25 |
Free Cash Flow | 70.62 | 106.56 | 128.27 | 120.11 | 75.61 | 167.03 |
Free Cash Flow Growth | -35.50% | -16.93% | 6.79% | 58.86% | -54.73% | 20.59% |
Free Cash Flow Margin | 13.03% | 20.29% | 27.03% | 25.45% | 16.55% | 41.57% |
Free Cash Flow Per Share | 0.44 | 0.66 | 0.96 | 1.00 | 0.63 | 1.39 |
Cash Income Tax Paid | 84.33 | 86.12 | 62.86 | 81.73 | 71.64 | 59.18 |
Levered Free Cash Flow | -52.65 | 14.87 | 114.93 | 106.55 | -37.4 | 211.19 |
Unlevered Free Cash Flow | -52.63 | 14.89 | 114.95 | 106.58 | -37.36 | 211.25 |
Change in Working Capital | -53.77 | -53.77 | 2.79 | -6.92 | -44.7 | 8.44 |